EUVIMEDEUVIMED entdecken
Leitlinie

First Report of National Consensus Guidelines for the Diagnosis and Treatment of Helicobacter pylori Infection in Iran

Aryan Salahi-Niri iD, Anahita Sadeghi iD, Marjan Mokhtare, Foroogh Alborzi Avanaki iD, Mohammad Taher, Afsaneh Mirshahvelayati, Mohammad Reza Zali, Amir Sadeghi iD, Abbas Yadegar iD

Helicobacter · 2026-05 · 31 (3)

DOI: 10.1111/hel.70137 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Helicobacter, online erschienen am 16.05.2026. Verfasst von Aryan Salahi-Niri und 8 weiteren Autor:innen. Beteiligte Einrichtung: Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical …. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter pylori. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 144 Literaturangaben. Gefördert von: Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences,….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Helicobacter pylori infection remains a major public health concern in Iran, where high prevalence, alarming antibiotic resistance, and significant gastric cancer burden necessitate a unified and evidence‐based national strategy. Despite the availability of international guidelines, gaps in clinical practice persist due to local epidemiology, resistance patterns, and diagnostic challenges. This study presents the first national Iranian consensus guideline for the diagnosis and management of H. pylori infection.

Methods

A multidisciplinary panel of experts from leading Iranian gastroenterology centers convened between August 2023 and October 2025. Using the GRADE framework, the scientific committee conducted systematic literature reviews and formulated evidence‐based statements across diagnostic, therapeutic, and clinical management domains. Consensus was defined as ≥ 80% agreement. Twelve structured meetings, including a final hybrid national consensus conference, were held to refine recommendations.

Results

The guideline delivers 35 evidence‐graded statements addressing indications for testing and treatment, optimal diagnostic modalities, and treatment pathways. Key recommendations include a strong preference for non‐invasive testing in patients under 45 without alarm features, endoscopic evaluation with targeted biopsies in high‐risk groups, and confirmation of eradication using urea breath test (UBT) or monoclonal stool antigen test (SAT) at ≥ 4 weeks post‐treatment. Given Iran's high clarithromycin resistance (> 20%), a course of 10–14 days bismuth quadruple therapy (BQT) is recommended as first‐line treatment, with non‐bismuth concomitant therapy as an alternative. Susceptibility‐guided therapy is encouraged when feasible, particularly after treatment failure. High‐dose proton pump inhibitor (PPI) or potassium competitive acid blocker (P‐CAB)‐based acid suppression is emphasized to enhance eradication efficacy. Special considerations are provided for renal/hepatic impairment and drug interactions.

Conclusion

This national guideline provides a standardized, evidence‐based framework for improving H. pylori diagnosis and management. By integrating local antimicrobial resistance patterns and practical clinical considerations, the guideline helps optimize eradication rates, reinforce antibiotic stewardship, and contribute to gastric cancer prevention efforts across Iran.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsHelicobacter pyloriHumansIranAnti-Bacterial AgentsDrug Resistance, BacterialProton Pump InhibitorsConsensus

Stichwörter der Autor:innen

Helicobacter pyloriIranantibiotic resistanceconsensus guidelinesdiagnosistreatment

Substanzen

Anti-Bacterial AgentsProton Pump Inhibitors

Autor:innen und Institutionen

  • Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Internal Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Imam Khomeini Hospital GI Ward, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Gastroenterology and Hepatology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Liver Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Aryan Salahi-Niri, Anahita Sadeghi, Foroogh Alborzi Avanaki, Amir Sadeghi, Abbas Yadegar

Förderung

  • Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences,…

Zitieren

APA

Salahi-Niri, A., Sadeghi, A., Mokhtare, M., Alborzi Avanaki, F., Taher, M., Mirshahvelayati, A., Zali, M. R., Sadeghi, A., & Yadegar, A. (2026). First Report of National Consensus Guidelines for the Diagnosis and Treatment of Helicobacter pylori Infection in Iran. Helicobacter, 31(3). https://doi.org/10.1111/hel.70137

Vancouver

Salahi-Niri A, Sadeghi A, Mokhtare M, Alborzi Avanaki F, Taher M, Mirshahvelayati A, et al. First Report of National Consensus Guidelines for the Diagnosis and Treatment of Helicobacter pylori Infection in Iran. Helicobacter. 2026;31(3). doi:10.1111/hel.70137

BibTeX
@article{SalahiNiri2026,
  author = {Salahi-Niri, Aryan and Sadeghi, Anahita and Mokhtare, Marjan and Alborzi Avanaki, Foroogh and Taher, Mohammad and Mirshahvelayati, Afsaneh and Zali, Mohammad Reza and Sadeghi, Amir and Yadegar, Abbas},
  title = {First Report of National Consensus Guidelines for the Diagnosis and Treatment of Helicobacter pylori Infection in Iran},
  journal = {Helicobacter},
  year = {2026},
  volume = {31},
  number = {3},
  doi = {10.1111/hel.70137}
}
Kostenlos starten →